Obalon Therapeutics Inc. (NASDAQ: OBLN) Attends 31st Annual ROTH Conference
Obalon Therapeutics (NASDAQ: OBLN) is a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity. The company is focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, visit the company's website at www.obalon.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to…







